ADMETRx, CeeTox Team Up to Help Clients Streamline Drug Discovery

The integration of ADMETRx's ADME evaluation and CeeTox's toxicity screening during drug discovery and lead optimization will help pharmaceutical and biotech companies efficiently improve their drug discovery decision making capabilities, a CeeTox official told CBA News.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.